UK small-cap RNS · 19 Jan 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
07:01
Marshalls MSLH £440mTrading Statement Trading updateConfirms 2025 adjusted profit in line with expectations after the revised £42-46m guidance; no upgrade, revenue +2% with H2 flat, and net debt lower than the £155m reported in October.Moved: Deliver annualised cost savings of about £11m from the 2023 restructuring (first: pending → on_track – Landscaping plan is on track to deliver £11m of annualised cost savings. · Landscaping Products return to revenue growth in 2025: on_track → missed – Landscaping revenue fell 1% in FY2025 (H1 and H2 both -1%), so the return to revenue growth did not happen, though volume grew 4%. · Reduce leverage and net debt from free cash flow: pending → on_track – Pre-IFRS16 net debt fell to £138m from £155m at 31 October 2025.
-
07:00
Anpario ANP £84mFull year trading statement Trading updateAnpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2025 ("FY 2025").ahead of expectationsfirst since Oct 2023 +7.4% on the day
-
07:00
Full Year Trading Update Trading updateFY25 adjusted EBITA is slightly ahead of market expectations, driven by margins near the top of the medium-term target, though revenue (c. £203m) is below the £205.8m consensus and organic growth was only 3%.£203.0m · 42% of mcapahead of expectationsoutlook positivefirst since Oct 2023 +14.2% on the dayMoved: Reduce leverage by end of 2025: below 1.5x, then below 1.3x, then 1.4x.: pending → delivered – Leverage ended 2025 under 1.4x, in line with the latest 1.4x target, and is expected to fall further. · Reduce group leverage to below 1x by December 2024.: pending → on_track – Leverage was under 1.4x at end-2025 and is expected to fall below 1.0x by end-2026, so the sub-1x aim is now pushed back from December 2024. · Growth to continue through 2025 in line with previous guidance.: pending → delivered – Group revenue grew c. 21% in 2025 with 3% organic growth, and adjusted EBITA came in slightly ahead of expectations.
-
07:00
Allergy Therapeutics AGY £285mHalf Year Trading Update Trading updateH1 revenue rises 7% to £36.3m despite the TAV phase-out, and Grassmuno launched in January. Debt is repaid, but cash is lower at £10.1m and no funding has been drawn.Moved: Grassmuno German launch: Marketing authorisation granted; launch anticipated Q1 2026 → Commercialisation commenced January 2026 · Potential equity raise: Authority sought; no investors or terms agreed → No raise agreed; £70m uncommitted debt funding available · Hong Kong dual listing: Announced 6 Nov 2025; expected first half 2026 → Still exploring potential dual primary listing
-
07:00
M&C Saatchi SAA £137mFY 2025 Trading Update Trading updateConfirms the cut November guidance: operating profit of £26m is at the bottom of the £26m-£28m range and the £12m savings are delivered. This removes further downside risk but gives no upside.in lineoutlook mixedfirst in 8 months +3.2% on the dayMoved: FY25 guidance and FY26 recovery: FY25 guidance cut on US shutdown → FY25 delivered at low end; profitable growth targeted FY26 · Share buyback programme: Board committed up to £5m over 12 months → Commitment reiterated, no execution update
-
07:00
Christie Group CTG £40mFull Year Trading Update Trading updateAfter the 23 December upgrade, strong December invoicing lifts FY25 continuing revenue above £70.0m and operating profit above £6.5m (2024: £3.5m), roughly double the prior year. Expectations were already raised once.ahead of expectationsoutlook mixedfirst since Oct 2023 +8.3% on the day
-
07:00
Trading Update - Six months to 31 December 2025 Trading updateMarket gains and strong EM and Listed PE returns lifted FuM 4% to $11.2bn, but client rebalancing and structural changes drove $853m of net outflows, so growth came from markets, not new money.outlook positive −0.8% on the day
-
07:00
Sigmaroc SRC £1,306mYear-end trading update Trading updateUnderlying EPS of c.10.5p is about 10% above prior guidance (at least 9.5p) and above 9.7p consensus, driven by synergies and cost control despite lower volumes.£18.0m · 1% of mcapahead of expectationsoutlook positive +7.0% on the dayMoved: new: Refinancing of banking facilities – Refinancing process started · new: Divestment programme – Three disposals agreed; programme formally closed
-
07:00
XP Power Ltd. XPP £478mFull Year Trading Update Trading updateXP Power, one of the world's leading developers and manufacturers of critical power control solutions to the Semiconductor Manufacturing Equipment, Healthcare and Industrial Technology sectors, is today issuing a trading update for the fourth quarter and full …in linefirst since Oct 2023 +11.8% on the day
-
07:00
Trading Update Trading updateTrading update for the year ended 31 December 2025in linefirst since Oct 2023 +1.8% on the day
-
07:00
Distil DIS £1.2mTrading Update Trading updateQ3 revenue fell 26% and distributor volumes fell 39% as Christmas stock was built in Q2, and margin dropped back to 42% from Q2's 50%. Consumer-level sales rose 36%, which only partly offsets this.Moved: Blackwoods Brand Home opening: Fit-out nearing completion; licence being processed → Opening due by end of January · Blavod US relaunch: Shipments delayed by TTB and US shutdown → TTB approval received; ready to ship · September 2025 equity fundraise: First tranche £378k received; general meeting held 30 September → Proceeds used for stock, packaging, EU set-up, Brand Home